Lir Life Sciences Corp. (CVE:SKNY) | WebDisclosure

Basculer en Français

9992	Companies
202692	Keywords
133296	Articles
107629	Press releases

Headlines Articles Press releases Lir Life Sciences Corp.

Home
Companies
Lir Life Sciences Corp.

PRESS RELEASE

published on 12/12/2025 at 00:00, 2 months 26 days ago

LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies
LIR Life Sciences files provisional patent for needle-free delivery platform for GLP/GIP therapies in obesity and metabolic diseases, aiming to improve treatment accessibility and adherence

Metabolic Diseases Obesity Provisional Patent GLP/GIP Therapies LIR Life Sciences
BRIEF

published on 12/11/2025 at 00:05, 2 months 27 days ago

Lir Life Sciences annonce une nouvelle étude sur les thérapies contre l'obésité

Administration Transdermique Thérapies Contre L'obésité Étude Des Peptides Hormones GLP/GIP Options Sans Aiguille
BRIEF

published on 12/11/2025 at 00:05, 2 months 27 days ago

Lir Life Sciences Announces New Study on Obesity Therapies

Transdermal Delivery Obesity Therapies Peptide Study GLP/GIP Hormones Needle-free Options
PRESS RELEASE

published on 12/11/2025 at 00:00, 2 months 27 days ago

Lir Life Sciences Completes Design of a Comparative Animal Study Investigating Cell-Penetrating Peptide-Mediated Delivery of GLP/GIP-Based Obesity Therapies
Lir Life Sciences Corp. announces a new comparative cell-penetrating peptide-based uptake study for GLP/GIP-based obesity therapies, enhancing transdermal delivery options. The study aims to improve treatment adherence and effectiveness for metabolic conditions

Transdermal Delivery Lir Life Sciences Corp. Obesity Therapies GLP/GIP Cell-penetrating Peptides
BRIEF

published on 11/26/2025 at 23:05, 3 months 10 days ago

Lir Life Sciences fait appel à MCS pour ses services de marketing numérique

Investissement Stratégique Relations Avec Les Investisseurs Développement De Médicaments Marketing Numérique Impact Des Devises
BRIEF

published on 11/26/2025 at 23:05, 3 months 10 days ago

Lir Life Sciences Engages MCS for Digital Marketing Services

Digital Marketing Investor Relations Strategic Investment Drug Development Currency Impact
PRESS RELEASE

published on 11/26/2025 at 23:00, 3 months 10 days ago

Lir Life Sciences Announces Engagement for IR Services
Lir Life Sciences Corp. engages MCS for online marketing services to enhance brand visibility and attract investors. Company focuses on developing obesity treatments through novel drug delivery methods

Online Marketing Services Lir Life Sciences Corp. MCS Obesity Treatments Drug Delivery Methods
BRIEF

published on 11/10/2025 at 15:05, 3 months 27 days ago

Lir Life Sciences Corp. Completes Acquisition of Lir Life Sciences Inc.

Acquisition Private Placement Leadership Changes Obesity Treatment CEO Change
BRIEF

published on 11/10/2025 at 15:05, 3 months 27 days ago

Lir Life Sciences Corp. finalise l'acquisition de Lir Life Sciences Inc.

Acquisition Placement Privé Changement De PDG Changements De Direction Traitement De L'obésité
PRESS RELEASE

published on 11/10/2025 at 15:00, 3 months 27 days ago

Lir Life Sciences Corp. Formerly Blackbird Critical Metals Corp. Announces Closing of Acquisition of Lir Life Sciences Inc.
Lir Life Sciences Corp. completes acquisition of Lir Inc., resumes trading on CSE under 'SKNY' ticker symbol. Dr. Edward Mills appointed CEO alongside new board and management members

Acquisition Board Changes CSE Lir Life Sciences Corp. Dr. Edward Mills

Accesswire

Published on 03/07/2026 at 00:00, 16 hours 48 minutes ago

Green Bridge Metals to Ship Titac Drill Core for Metallurgical Testing to Evaluate Titanium Dioxide Extraction Potential
Published on 03/06/2026 at 22:30, 18 hours 18 minutes ago

Sceptre Ventures Announces Amendment and Closing of Private Placement Offering
Published on 03/06/2026 at 22:00, 18 hours 48 minutes ago

Pegasus Resources Inc. Announces Annual General and Special Meeting of Shareholders
Published on 03/06/2026 at 17:55, 22 hours 53 minutes ago

High Tide Resources Announces Upsize to Private Placement
Published on 03/06/2026 at 14:00, 1 day 2 hours ago

CHAR Technologies Announces Increase to C$ 3.97M and Closing of Book on Previously Announced Private Placement

View all ACCESSWIRE

EQS Group

Published on 03/07/2026 at 15:15, 1 hour 33 minutes ago

CGTN: How China builds consensus, boosts development through consultative democracy
Published on 03/07/2026 at 02:03, 14 hours 45 minutes ago

EQS-Adhoc: Heidelberg Pharma and HealthCare Royalty Announce Amendment to Existing Royalty Agreement and the Participation of Soleus Capital
Published on 03/06/2026 at 23:05, 17 hours 43 minutes ago

DeFi Technologies Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
Published on 03/06/2026 at 19:30, 21 hours 18 minutes ago

TRADE SHOWS: IEG, OUTSTANDING RESULTS FOR KEY - THE ENERGY TRANSITION EXPO WITH +10% TOTAL VISITORS AND +9% FROM ABROAD
Published on 03/06/2026 at 18:44, 22 hours 3 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 03/06/2026 at 18:05, 22 hours 43 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 28/02/2026
Published on 03/06/2026 at 18:05, 22 hours 43 minutes ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 28/02/2026
Published on 03/06/2026 at 18:00, 22 hours 48 minutes ago

Outstanding shares and voting rights statement at 28 February 2026
Published on 03/06/2026 at 18:00, 22 hours 48 minutes ago

Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 28 février 2026
Published on 03/06/2026 at 18:00, 22 hours 48 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 27 février 2026

View all LES ECHOS COMFI WIRE